Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Do you understand why they are keeping the stop sign on? Its called toxic debt, as long as the stop sign is on they cant convert and kill the price to .0001. Daniel is correct not to clear the stop sign until he negotiates them out of the deal with Continuation Capital. Thats my take
From what I understand we wont have to worry about buying, these guys are online marketing wiz kids. This will be so self promoted they will have a cult like following. Just think how many people they email addresses on. Im telling you they know what their doing and they are very efficient on execution. I personally think they will do their capital raise before the split so they will have a float when its done.
I'm hearing a beverage deal is complete and will be announced very soon. Its with a large multinational beverage company. Will be big when announced.
Just sayin
7 million
CBD water deal coming
Just sayin
I think we are getting close to something big happening. That would explain the recent corporate changes. Major consolidation going on in the industry. Get ready
Active Twitter ad campaign
Im seeing about 10 clkia ads on Twitter the last few days
Sony release
Clikia Adds Sony Movie Channel® to Basic Channel Lineup as Channel 36; Addition of Iconic Worldwide Brand Indicative of Strength of Clikia Within the Rapidly Expanding Streaming (OTT) Marketplace
Post split cap structure
Shares outstanding: 2,560,000 shares
Public float: 1,028,000 shares
Whith that Sony release yesterday this could make a nice run. Plus who would sell down here anyway.
Just sayin
This release also set the roadmap for the future. Catch some key words in release. Ex:other claims, significant growth. Sounds like they have funding.
JUST SAYIN
#INTK Late yesterday reached an agreement to partner with established successful general contractor in New York City to offer product & installation for steam pipes and boilers. Starting with apartment buildings and factories. Ultimate objective: https://t.co/1HStLCMenF
Someone needs to get on the ball might need to look somewhere else. Shortsighted
Cant say but its substantial and will give this company a renewed future.
Just Sayin
We both might know the same thing
Huge
Its bigger then anyone could imagine
Just Saying
Go Epic Health to Begin Next Round of Clinical Studies for Cholesterade®Press Release | 03/21/2018
Leone Asset Management announces that their subsidiary Go Epic Health is beginning their next clinical study for Cholesterade®
St. Petersburg, FL, March 21, 2018 (GLOBE NEWSWIRE) -- James Price, CEO of Go Epic Health, stated, “We are extremely excited to begin the next round of clinical studies on Cholesterade®. When Dr. Cade first created the product he conducted case studies at the University of Florida and had amazing results in the study. Recently, Dr. Richard Goldfarb conducted a proof of concept study to once again prove the efficacy of Cholesterade® on lowering cholesterol and also experienced amazing and similar results as Dr. Cade. The next round of studies will be a much larger scale as well as being conducted in a multi-center program.”
The research study is to validate the use of Cholesterade® to improve lipid profiles of individuals and examine the cardiovascular benefits of this reduction in lipids.
The research study will involve the use of human subjects and thus will need to be in a clinical setting. It will also require prior IRB approval. We intend to use Western IRB for study protocol approval. The study will be conducted in several clinic locations in the Memphis, Tennessee area and will use Cleveland Heart Labs advanced Lipid screen for lab draws and test results.
The genesis of this study is based on a previous case study conducted on Cholesterade® namely - Effect of two Dietary Soluble Fibers on Cholesterol and Triglyceride Concentrations in Human Plasma - which showed robust improvement in Lipid profiles of test subjects within 4 weeks of use including LDL, HDL, Total Cholesterol and Triglycerides.
We want to build on the results of that study and further explore the medium and long-term effects of Cholesterade® on reduction in lipids and improvement in overall lipid profile as a cardio-protective mechanism for improved clinical outcomes in test subjects.
This new proposed study will involve human subjects who will have baseline Total Cholesterol, LDL, HDL, TG and advanced Lipids. These advanced Lipids and Arterial Inflammatory markers have been shown to be elevated in subjects vulnerable to an impending cardiovascular adverse event.
In addition to the standard Lipid profile mentioned above and as tested in the previous study, we will be testing for F2-IsoPs, OxLDL - which correlate with lifestyle concerns. ADMA/SDMA, Microalbumin, hsCRP - which correlate with development of metabolic or cardiovascular disease, Lp-PLA2 Activity, MPO - which correlate with formation of vulnerable plaque and increased risk for an adverse event.
We will also check for advanced Lipid particles - Apolipoprotein B (ApoB) and A1 (ApoA1), Small-Dense LDL (sdLDL), Lipoprotein (a) (Lp(a)) and HDL2b – which address additional risk factors for Cardiovascular disease including the number of atherogenic particles, the size of these particles and the inherent risk of developing CVD.
These labs will be drawn at baseline before the start of the study period. After signing a consent form to be a part of the study protocol, these subjects will then be randomized into the Cholesterade® or Placebo group for a period of 12 months without changing any lipid lowering therapy. An attempt will also be made to keep medication profiles unchanged over the course of the study period.
These subjects will undergo a 3-month, 6-month, 9-month and 12-month follow up clinic visits and have the same labs drawn on each visit.
We will longitudinally follow these patients and also look for cardiovascular outcomes including new onset Diabetes, Hypertension, Cardiovascular event (defined as Unstable Angina, NSTEMI or STEMI) and Ischemic Stroke during the study period.
We will try to propensity match the placebo and treatment groups. We will look to minimize confounding. The Lipid profiles and change in lipid particle values will be statistically evaluated. We will also compare cardiovascular outcomes as defined in the protocol between the placebo and treatment groups.
We will also look at adverse reactions and side effect profile of the product during this research study.
The results will be published in a peer-reviewed journal and be available on PubMed for review and viewing. We expect to validate the findings of the previous case series and add to the value of Cholesterade® by showing improved lab results not only in the standard lipid panel but advanced lipids and inflammatory markers which are more reliable markers of Cardiovascular disease risk. This will put Cholesterade® on the forefront of Cardiovascular disease prevention as an over the counter non-medicinal product and further enhance its market share.
We will also explore the possibility of doing a Meta-analysis of clinical data involving the use of Cholesterade® product in various clinical outcomes. This will evolve as more trials are conducted using the Cholesterade® product.
About Leone Asset Management
Leone Asset Management, Inc., is a multi-national, multi-industry conglomerate with subsidiary companies that operate in Health and Wellness, Infrastructure development and agriculture management. For additional information, visit: www.leoneasset.com.
About Go Epic Health
Go Epic Health, a Leone Asset Management subsidiary, is a nutritional product holding company which owns the intellectual property and worldwide manufacturing and distribution rights to Cholesterade®, a natural cholesterol reducing product created by the late Dr. Robert Cade, creator of Gatorade®. Go Epic Health markets and distributes Cholesterade® as well as other new and innovative consumer goods through the nation's largest retail pharmacy chain stores, drug and health food stores and product specific catalogs. For further information, please visit www.goepichealth.com and www.cholesterade.com.
Forward-Looking Statements Disclosure:
This press release may contain "forward-looking statements" within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company's expected future business and financial performance, and often contain words such as "anticipates," "beliefs," "estimates," "expects," "intends," " plans," "seeks," "will," and other terms with similar meaning. These forward-looking statements by their nature address matter that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.
Woody Junot President Go Epic Health (727) 581-1500 wjunot@goepichealth.com
Not a pumpster time will tell
Im hearing additional acquisition coming
Stop sign removed financials up to date with consistent revenue. Tight float should see big move here.
Hearing big things coming with big revs
Why do you need a box I just downloaded the app works perfectly. If I were you that's what I would do
Looks like they are booking revenue I have the Premium Package and love it picture quality is excellent. Ive been using a ubs cord and watching on my 50in tv Now all they need is a major ad campaign which is in the works as we speak. Was told they are ready to scale their growth
Plan is taking hold way to go Dave more to come
All Premium Channels are listed on the Guide they are getting ready to flip the switch.
Im seeing ESPN Weather Channel FOX NEWS CNN MSNBC CNBC, ect they are all there. Way to go David
if they were hiding they would not file the qtr's reports.
You sure act like someone who owns 0 shares
Those are the reported numbers I dont know the moderator of this page but the info is not correct you should always look at the filings
look at the qtr filings on otcmarkets
https://www.otcmarkets.com/financialReportViewer?symbol=CLKA&id=177896
So lets use your assumption how many shares would be too many shares issued from the last qtr report. 279,814,672. Or do you think investors want to just donate funds to the company.
6/30/17 whats your definition of well before
were talking about 90 day ago
So when was it gagged
hey file each QTR look at their filings for dilution.
I did that for you
6/30/17
279,814,672 shares outstanding
6/30/17
242,814,672 shares outstanding
So in 1 year they issued
37,000,000 shares
Where is this massive dilution you speak of.
they file each QTR look at their filings for dilution.
I did that for you
6/30/17 6/30/16
279,814,672 242,814,672
So in 1 year they issued
37,000,000 shares
Where is this massive dilution you speak of.
From what I understand CLKA made payment to content provider and are in the process of linking to their site.Its happening
Will management fire Hayley Geftman-Gold (Haley Lattman)her position is VP Business Affairs. She posted that "I'm actually not even sympathetic bc country music fans often are republican gun toters."
So let Take Two know too fire her asap. Shame on them if they dont
I think you want to own this before the open Monday morning
I think next week on channel release
I have a feeling that October will definitely be launch month. Also on the heals of Roku IPO up 67% first day of trading. We are in the right sector. It's about to get real fun. You guys have a reason to be skeptical, but I feel this time for real.
oh buying at the close
Closer then most think, thats all Im saying
Here is an exercise we should all explore. If there is some dilution at what cost to the company will it be accounted for. Did it pay for the advancement of the company's business plan and allow management to meet or exceed expectations. In addition, will this hypothetical investment allow the company to increase subscriber base to a level that gets the attention of the powers in the industry.
Data points for exercise:
Amount invested
Shares issued
Revenue expectation
Number of subscribers
Industry value per subscriber
Let's play around with the numbers then post your results for an open discussion. I feel that will put each of our words into numbers.